Type of drug related action performed during the visit | Number of visits with requirement of drug information to perform certain type of action, N (%) | Proportion of visits in which the patient provided additional essential information during MR compared to: | ||||
---|---|---|---|---|---|---|
EMR, N (%) | EMR plus NMRS, N (%) | |||||
Rheumatologists | Expert panel | Rheumatologist | Expert panel | Rheumatologist | Expert panel | |
Change drugs (n = 24) | 20 (83) | 24 (100) | 7 (35) | 9 (38) | 0 (0) | 1 (4) |
Discuss DRPs (n = 17) | 8 (47) | 15 (88) | 0 (0) | 11 (73) | 0 (0) | 9 (60) |
Change drugs and discuss DRPs (n = 29) | 5 (21) | 20 (83) | 0 (0) | 4 (20) | 0 (0) | 2 (10) |
Perform all drug-related actions (n = 65) | 33 (51) | 59 (91) | 7 (21) | 24 (41) | 0 (0) | 12 (20) |
Total number of visits (n = 83) | 33 (40) | 59 (71) | 7 (8) | 24 (29) | 0 (0) | 12 (14) |